...
首页> 外文期刊>Advanced Science Letters >In-Situ Coating of 2-Methacryloyloxyethyl Phosphorylcholine Polymer on Polysulfone Hollow Fiber Membranes for Hemodialysis
【24h】

In-Situ Coating of 2-Methacryloyloxyethyl Phosphorylcholine Polymer on Polysulfone Hollow Fiber Membranes for Hemodialysis

机译:聚砜中空纤维膜上原位包覆2-甲基丙烯酰氧基乙基磷酸胆碱聚合物用于血液透析

获取原文
获取原文并翻译 | 示例
           

摘要

Hemodialysis is the clinical technique used for the treatment of people suffering from the kidney diseases. Despite of the popularity of polysulfone as a membrane material for hemodialyis, the biocompatibility remains a major concern. To improve the hemocompatinility, composite hollow fiber membranes (HFMs) were prepared using with two type of commercial MPC (2-methacryloyloxyethyl phosphorylcholine) differentiated by solvent solubility. Polysulfone-based hollow fiber lumen was in-situ coated with MPC during coagulation. The small quantity of cross link-able MPC polymer in water and ethyl alcohol was used as bore fluid. The composite biocompatible membranes showed the presence of MPC coating on hollow fiber lumen as confirmed by the FTIR. The hemocompatibility of both the membranes was confirmed by the hemolysis and platelet adhesion. The cytocompatibility of the material was determined by growing the NIH3T3 fibroblast cell line and checking the growth of cells by confocal imaging. Both the compounds were found to be hemocompatible and cytocompatible. However the solvent used for making the bore solution has a vital role in defining final membrane morphology and performance. The membranes prepared with water based MPC has the cutoff similar to the native polysulfone membrane but the alcohol based MPC membrane has a broad cutoff. Uniform nanopores in the Psf and water based MPC HFMs was formed, whereas macropores along with nanopores are formed in the alcohol based MPC HFMs. Thus the in-situ coating process during the manufacture of the hollow fiber membrane is an attractive and economic way of making biocompatible HFMs.
机译:血液透析是用于治疗患有肾脏疾病的人的临床技术。尽管聚砜作为用于血液透析的膜材料很受欢迎,但是生物相容性仍然是主要关注的问题。为了提高血液相容性,使用两种通过溶剂溶解度进行区分的商业MPC(2-甲基丙烯酰氧基乙基磷酰胆碱)制备复合中空纤维膜(HFM)。在凝结过程中,将聚砜基中空纤维管腔原位涂有MPC。水和乙醇中的少量可交联的MPC聚合物用作钻井液。 FTIR证实,复合生物相容性膜显示中空纤维内腔上存在MPC涂层。通过溶血和血小板粘附来确认两个膜的血液相容性。通过生长NIH3T3成纤维细胞系并通过共聚焦成像检查细胞的生长来确定材料的细胞相容性。发现这两种化合物是血液相容的和细胞相容的。然而,用于制备孔溶液的溶剂在确定最终膜的形态和性能方面起着至关重要的作用。用水基MPC制备的膜具有与天然聚砜膜相似的截止值,但基于醇的MPC膜具有较宽的截止值。在Psf和基于水的MPC HFM中形成了均匀的纳米孔,而在基于醇的MPC HFM中形成了大孔以及纳米孔。因此,在中空纤维膜的制造过程中原位涂覆工艺是制备生物相容性HFM的有吸引力且经济的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号